Fredrikson & Byron Represents Bio-Techne Corporation in its Acquisition of Zephyrus Biosciences, Inc.

April 8, 2016

Fredrikson & Byron acted as legal counsel to Bio-Techne Corporation (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, in its acquisition of Zephyrus Biosciences, Inc. Zephyrus Biosciences will be integrated into the Protein Platforms Division of Bio-Techne. Zephyrus Biosciences provides research tools to enable protein analysis at the single cell level. Fredrikson’s legal team was led by Joseph J. Schauer, Ryan C. Brauer and Andrew M. Nick.

Read the news release.